Irinotecan (Meditab) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: irinotecan
Pack: Irinotecan (Meditab) 40 mg/2 mL injection, 2 mL vial
Brand name
(ARTG)
: MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 40 mg / 2 mL injection vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
As a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. Patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection
- Intravenous
- Clear colourless to yellow solution
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- Vial 40 mg / 2 mL pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient irinotecan
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
